Skip to main content
. 2017 Apr 5;12(2):291–297. doi: 10.1111/jnp.12122

Table 1.

Summary of participant demographics (means ± SE)

Patients (= 7) Controls (= 18) Difference
Gender (M:F) 6:1 11:7 χ2(1, 25) = 1.40, n.s.
Age 39.1 (1.0) 35.9 (2.6) t(23) = 0.93, n.s.
Education 11.1 (1.5) 11.1 (0.7) t(23) = 0.10, n.s.
UPDRS 69.7 (9.53) N/A N/A
Duration of methcathinone use 5.1 years (2.2) N/A N/A
LARS −16 (2.7) −25 (1.6) t(23) = 2.57, = .02
BDI 20.7 (5.7) 8.1 (1.1) t(23) = 1.91, n.s.